Heat Shock Protein 90 Inhibitor Effects on Pancreatic Cancer Cell Cultures

Conclusions Novel Hsp90 inhibitors can be developed as antipancreatic cancer agents. Their chemical structures are simpler, and they are likely to exhibit lower side effects than the much more complex inhibitors used as controls.
Source: Pancreas - Category: Gastroenterology Tags: Original Articles Source Type: research